Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03715127

Organisation Name: University of Zurich

Overal Status: Recruiting

Start Date: March 11, 2019

Last Update: November 4, 2020

Lead Sponsor: University of Zurich

Brief Summary: Effects of serotonin 2A/1A receptor stimulation by psilocybin on mood and emotion processing in major depressive disorder: a randomized double-blind placebo-controlled study

Conditions:
  • Depressive Disorder, Major


Total execution time in seconds: 0.16859579086304